fda compounding semaglutide crackdown 2025 news September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines Troubling Findings in Study of

Patients who experience intolerable side effects at any dose can remain at their current level longer before titrating upward

We need to expand addiction medicine education in medical school and residency training, Leggio says

What You'll Discover: What retatrutide is and how it works in the body

Weight loss at week 52 averaged 15.6 percent and at week 104 averaged 15.2 percent

GLP-1 (glucagon-like peptide-1) receptor agonists are a type of injectable medication originally developed to manage type 2 diabetes

Bangerter-Rhyner Foundation, and a top-up stipend from the PhD Program Health Sciences, University Hospital Basel, Switzerland (to COS)